SonoThera
An Executive Assistant role supporting the CEO at a genetic medicine company, focusing on calendar management, travel coordination, and executive operations. The role requires high-level administrative support and strategic execution across internal and external engagements.
Headquarters
South San Francisco, California, United States
Company Size
11-50 employees
SonoThera is a biotech company developing what it describes as the world’s first ultrasound‑mediated, nonviral technology for gene delivery. Their ultrasound‑guided platform is designed to enable targeted, in vivo delivery of nucleic acids without viral vectors, addressing limits of safety, immunogenicity, payload size, and repeat dosing. SonoThera aims to translate this delivery infrastructure into broad genetic-medicine applications as a safer, more scalable alternative to viral gene therapies.
SonoThera Presents New Preclinical Data at MDA 2026 Highlighting RIPPLE™ as an Efficient, Scalable,
23 hours ago
J.P. Morgan Healthcare Conference to Advance Multiple Genetic Medicine Programs Toward First-in-Human Studies
Jan 8, 2026
SonoThera Presents New Data at ASN Kidney Week 2025 Demonstrating Full-Length Col4a5 Gene Expression Using Ultrasound Mediated Gene Delivery in Treating X-Linked Alport Syndrome
Nov 6, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for SonoThera.
50% above the average for this role
SonoThera: $125 Million Series B Raised To Advance Ultrasound-Mediated Genetic Medicines Toward First-In-Human Trials
1 month ago